About Belco Pharma Private Limited
Data last updated:
Belco Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2020PTC360147. Its GSTIN is 07AAICB8561A1ZT (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kapil Singla and Puneet Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 395 Kohat Enclave, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.2 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹35.48 Lakh (net margin -290.8%) and EBITDA of -₹29.46 Lakh (EBITDA margin -241.5%).
The company is associated with 1 brand: Belco Pharma. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
For more details, the company can be reached via its website belcoindia.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address395 Kohat Enclave, New Delhi, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Belco Pharma Private Limited
Belco Pharma operates one associated brand: Belco Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, development, and exports of formulations in India. | belcoindia.com |
Business Activity of Belco Pharma Private Limited
The main business activity of Belco Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Belco Pharma Private Limited FY 2025 filings available
Belco Pharma Private Limited reported revenue of ₹12.2 Lakh (down 76% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Belco Pharma Private Limited
Revenue fell 76% in the latest year. EBITDA fell 479% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Belco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹29.46 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹35.48 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Belco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -241.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -290.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Belco Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Belco Pharma Private Limited
Belco Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kapil Singla | Director | 10 Jan 2020 | 6 Years 9 Months | Current |
| Puneet Singla | Director | 10 Jan 2020 | 6 Years 9 Months | Current |
Peer Comparison of Belco Pharma Private Limited
Belco Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gurukulherbal and Ayurved India Private Limited | ₹12.22 Lakh (FY 2025) | •••• | •••• | 511.0% | •••• | Hardwar, Uttarakhand, India |
| Saikrupa Detergent and Chemicals Private Limited | ₹12.22 Lakh (FY 2020) | •••• | •••• | 2.0% | •••• | Bharuch, Gujarat, India |
| Sayar Sons Detergents Pvt Ltd | ₹12.22 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Telangana, India |
| Coromandel Indag Products India Limited | ₹12.22 Lakh (FY 2025) | •••• | •••• | 80.0% | •••• | Chennai, Tamil Nadu, India |
| Vertice Lifesciences Private Limited | ₹12.2 Lakh (FY 2024) | •••• | •••• | -7.0% | •••• | Karnal, Haryana, India |
| Belco Pharma Private Limited this company | ₹12.2 Lakh (FY 2025) | •••• | •••• | -76.0% | •••• | New Delhi, Delhi, India |
| Adhesive S V India Private Limited | ₹12.2 Lakh (FY 2022) | •••• | •••• | •••• | Haridwar, Uttarakhand, India | |
| Madind Pharma Private Limited | ₹12.2 Lakh (FY 2024) | •••• | •••• | 1125.0% | •••• | Patna, Bihar, India |
| Lowell Marketing Concept Private Limited | ₹12.2 Lakh (FY 2020) | •••• | •••• | 241.0% | •••• | Kanpur Nagar, Uttar Pradesh, India |
| Rollex Paints and Chemicals Pvt Ltd | ₹12.19 Lakh (FY 2025) | •••• | •••• | -33.0% | •••• | Cuttack, Odisha, India |
| MN Masks Private Limited | ₹12.19 Lakh (FY 2024) | •••• | •••• | -71.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Belco Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Belco Pharma Private Limited
Belco Pharma Private Limited is audited by AKGVG & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AKGVG & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Belco Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Belco Pharma Private Limited
Belco Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Belco Pharma Private Limited
Belco Pharma Private Limited has 2 court cases on record: 2 filed by Belco Pharma. 1 case is pending and 1 is disposed. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Export Credit Guarantee Coporation of India Limited | Pending |
| District court, Jhajjar, Haryana | Commercial suit | Filed by the company against Unimax Pvt. Ltd | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Belco Pharma Private Limited
Belco Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 4 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Akgvg and Associates | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Belco Pharma Private Limited
Employment history and EPFO contributions of people linked to Belco Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Belco Pharma Private Limited
Belco Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Kapil Singla was appointed as Director on 10 Jan 2020.
Credit Ratings, Litigation & Regulatory Alerts for Belco Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Belco Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Belco Pharma Private Limited
Belco Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICB8561A1ZT | Delhi | Active | 05 May 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Belco Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Belco Pharma Private Limited
Belco Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 January 2020 (6+ years old) and is registered under CIN U74999DL2020PTC360147.
Belco Pharma reported revenue of ₹12.2 Lakh for FY 2025 (down 76% YoY).
Belco Pharma has 2 current directors:
- Kapil Singla - Director
- Puneet Singla - Director
Belco Pharma reported a net loss of ₹35.48 Lakh (net margin -290.8%) and EBITDA of -₹29.46 Lakh (EBITDA margin -241.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Belco Pharma is 07AAICB8561A1ZT, registered in Delhi.
The CIN (Corporate Identification Number) of Belco Pharma is U74999DL2020PTC360147. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Belco Pharma has 2 court cases on record: 2 filed by the company. 1 is pending. Most are in the high courts.
Belco Pharma was incorporated on 10 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Belco Pharma by revenue are Gurukulherbal and Ayurved India Private Limited, Saikrupa Detergent and Chemicals Private Limited, Sayar Sons Detergents Pvt Ltd, Coromandel Indag Products India Limited, Vertice Lifesciences Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kapil Singla was appointed as Director on 10 Jan 2020. Puneet Singla was appointed as Director on 10 Jan 2020.
Belco Pharma has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 4 overdue payments to 1 micro and small supplier. The latest return was filed on 30 Aug 2023.
Belco Pharma can be reached through the website belcoindia.com. Its registered office is in New Delhi, Delhi, India.